(272 days)
No
The description focuses on a physical thermal regulation catheter and its connection to an external heater/cooler system, with no mention of AI or ML in the device's function or control.
Yes
The device is described as a thermal regulating device used to control patient temperature, which is a therapeutic function.
No
The device is described as a "thermal regulating device" intended to "control the patient temperature," and its function involves circulating fluid in a closed loop system to modulate temperature, not to diagnose a condition.
No
The device description clearly describes a physical catheter made of polyurethane with lumens, intended for placement in the esophagus and connection to an external heater cooler. This is a hardware device, not software only.
Based on the provided information, the EsoCool catheter is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to control patient temperature by circulating fluid in a closed loop system within the esophagus. This is a therapeutic and physiological intervention, not a diagnostic test performed on samples taken from the body.
- Device Description: The description details a device for direct patient contact and temperature regulation, not for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing blood, urine, tissue, or any other biological sample. The device's function is entirely focused on influencing the patient's body temperature.
IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. The EsoCool catheter does not fit this definition.
N/A
Intended Use / Indications for Use
The EsoCool catheter is a thermal regulating device intended to connect to a Gentherm Blanketrol III Hyper-Hypothermia System to control the patient temperature.
Product codes
PLA
Device Description
The EsoCool Thermal Regulation Catheter is a dual lumen tube that is placed in the esophagus. The two lumens are connected to an external heater cooler to allow for circulation of cold or warm fluid in a closed loop system. Heater cooler control is used to modulate the fluid temperature and control of patient's temperature. The EsoCool catheter is made of polyurethane with barium sulfate for radiopacity. The EsoCool catheter is a single-use, disposable, non-implantable device with an intended duration of use of 24 hours or less.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
esophagus
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench and animal testing was performed to confirm conformance to the special controls per 21 CFR 870.5910.
Bench testing included:
- Mechanical integrity testing,
- Compatibility with the designated external heater cooler, and
- Product stability through the designated shelf-life.
Animal testing included:
- Temperature change rate in the porcine animal model,
- Gross and light microscopy assessment of the esophagus to demonstrate no esophageal injury, and
- Temperature profile to demonstrate appropriate boundaries of body temperature in the porcine animal model.
In conclusion, non-clinical testing demonstrate that the device is safe and as effective as the legally marked predicate device as identified above.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5910 Esophageal thermal regulation device.
(a)
Identification. An esophageal thermal regulation device is a prescription device used to apply a specified temperature to the endoluminal surface of the esophagus via an external controller. This device may incorporate a mechanism for gastric decompression and suctioning. The device is used to regulate patient temperature.(b)
Classification. Class II (special controls). The special controls for this device are:(1) The patient contacting materials must be demonstrated to be biocompatible.
(2) Non-clinical performance evaluation must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested:
(i) Mechanical integrity testing.
(ii) Testing to determine temperature change rate(s).
(iii) Testing to demonstrate compatibility with the indicated external controller.
(iv) Shelf life testing.
(3) Animal testing must demonstrate that the device does not cause esophageal injury and that body temperature remains within appropriate boundaries under anticipated conditions of use.
(4) Labeling must include the following:
(i) Detailed insertion instructions.
(ii) Warning against attaching the device to unintended connections, such as external controllers for which the device is not indicated, or pressurized air outlets instead of vacuum outlets for those devices, including gastric suction.
(iii) The operating parameters, name, and model number of the indicated external controller.
(iv) The intended duration of use.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square. Next to that is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
June 27, 2024
Nuvaira, Inc. John Carline Sr. Director of Regulatory/Quality 6500 Wedgewood North, Suite 100 Maple Grove, Minnesota 55311
Re: K233357
Trade/Device Name: EsoCool Thermal Regulation Catheter Regulation Number: 21 CFR 870.5910 Regulation Name: Esophageal Thermal Regulation Device Regulatory Class: Class II Product Code: PLA Dated: May 28, 2024 Received: May 28, 2024
Dear John Carline:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Nicole M. Gillette -S
Nicole Gillette Assistant Director DHT2B: Division of Circulatory Support, Structural and Vascular Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K233357
Device Name EsoCool Thermal Regulation Catheter
Indications for Use (Describe)
The EsoCool catheter is a thermal regulating device intended to connect to a Gentherm Blanketrol III Hyper-Hypothermia System to control the patient temperature.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
X Prescription Use (Part 21 CFR 801 Subpart D)
_ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
| Contract Details | |
|---|---|
| Applicant Name and | |
| Address: | Nuvaira, Inc. |
| 6500 Wedgwood Road North, Suite 100 | |
| Maple Grove, MN 55311 | |
| United States | |
| Applicant Contact | |
| Information: | John Carline |
| Sr. Director of RA/QA | |
| Tel: 763-450-2819 | |
| Email: jcarline@nuvaira.com | |
| Device Name | |
| Device Trade Name: | EsoCool Thermal Regulation Catheter |
| Common Name: | Esophageal thermal regulation device |
| Classification Name: | Esophageal thermal regulation device |
| Regulation Number: | 870.5910 |
| Product Code: | PLA |
| Legally Marketed Predicate Devices | |
| Predicate Number: | K172493 |
| Predicate Trade Name: | EnsoETM |
| Predicate Product Code: | PLA |
Device Description Summary:
The EsoCool Thermal Regulation Catheter is a dual lumen tube that is placed in the esophagus. The two lumens are connected to an external heater cooler to allow for circulation of cold or warm fluid in a closed loop system. Heater cooler control is used to modulate the fluid temperature and control of patient's temperature. The EsoCool catheter is made of polyurethane with barium sulfate for radiopacity. The EsoCool catheter is a single-use, disposable, non-implantable device with an intended duration of use of 24 hours or less.
Intended Use/Indications for Use:
The EsoCool catheter is a thermal regulating device intended to connect to a Gentherm Blanketrol III Hyper-Hypothermia System to control the patient temperature.
Indications for Use Comparison to Predicate Device:
Indications for use is the same as the predicate device in that both are intended to control the patient temperature. The EsoCool catheter does not incorporate the optional mechanism for gastric decompression and suctioning and as such does include the indications statement related to gastric decompression and suctioning.
4
Technological Comparison to Predicate Device:
Technological characteristics are the same in that both provide a dual lumen tube to an external heater cooler for circulation of fluid in closed loop system. One difference is that the outer lumen of the EsoCool catheter is radiopacity of catheters is common across many cardiovascular catheters and does not constitute a novel technological characteristic.
Non-Clinical and/or Clinical Tests Summary and Conclusions:
Bench and animal testing was performed to confirm conformance to the special controls per 21 CFR 870.5910.
Bench testing included:
-
- Mechanical integrity testing,
-
- Compatibility with the designated external heater cooler, and
-
- Product stability through the designated shelf-life.
Animal testing included:
-
- Temperature change rate in the porcine animal model,
-
- Gross and light microscopy assessment of the esophagus to demonstrate no esophageal injury, and
-
- Temperature profile to demonstrate appropriate boundaries of body temperature in the porcine animal model.
In conclusion, non-clinical testing demonstrate that the device is safe and as effective as the legally marked predicate device as identified above.